Oaktree Acquisition Corp. III Life Sciences’ (NASDAQ:OACCU – Get Free Report) lock-up period is set to expire on Tuesday, April 22nd. Oaktree Acquisition Corp. III Life Sciences had issued 17,500,000 shares in its IPO on October 24th. The total size of the offering was $175,000,000 based on an initial share price of $10.00. After the expiration of the company’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.
Oaktree Acquisition Corp. III Life Sciences Stock Performance
OACCU stock opened at $10.31 on Friday. Oaktree Acquisition Corp. III Life Sciences has a twelve month low of $9.99 and a twelve month high of $10.60. The stock has a fifty day simple moving average of $10.26.
Institutional Trading of Oaktree Acquisition Corp. III Life Sciences
Several institutional investors and hedge funds have recently modified their holdings of OACCU. Kepos Capital LP purchased a new stake in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth about $709,000. Rangeley Capital LLC purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 4th quarter worth approximately $101,000. Athos Capital Ltd bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at approximately $507,000. ADAR1 Capital Management LLC purchased a new position in Oaktree Acquisition Corp. III Life Sciences during the fourth quarter valued at approximately $5,065,000. Finally, Affinity Asset Advisors LLC bought a new position in Oaktree Acquisition Corp. III Life Sciences in the fourth quarter worth approximately $2,538,000.
Oaktree Acquisition Corp. III Life Sciences Company Profile
We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.
Featured Articles
- Five stocks we like better than Oaktree Acquisition Corp. III Life Sciences
- How to Use Stock Screeners to Find Stocks
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- Growth Stocks: What They Are, Examples and How to Invest
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- What is MarketRank™? How to Use it
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.